학술논문
Preliminary Safety of PDS0101 (Versamune +HPVmix) and Pembrolizumab Combination Therapy in Subjects with Recurrent/Metastatic Human Papillomavirus-16 Positive Oropharyngeal Squamous Cell Carcinoma (OPSCC)
Document Type
Abstract
Author
Source
In International Journal of Radiation Oncology, Biology, Physics 1 April 2022 112(5):e37-e38
Subject
Language
ISSN
0360-3016